NCT05152862

Brief Summary

The aim of the study is to assess whether a delay of the first examination can be safely considered in French population. Secondary objectives are to describe retinopathy of prematurity (ROP) in a population of premature from two French tertiary NICU and to identify co-morbidities associated with the development of severe ROP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
886

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 10, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2022

Completed
Last Updated

November 26, 2024

Status Verified

September 1, 2022

Enrollment Period

3 months

First QC Date

November 19, 2021

Last Update Submit

November 22, 2024

Conditions

Keywords

birth weightgestational ageprematureretinascreening

Outcome Measures

Primary Outcomes (1)

  • Number of infants with type 1 or 2 ROP found at routine screening.

    Number

    Day 0

Secondary Outcomes (3)

  • Time from first retinal examination to treatment of ROP

    Day 0

  • Postnatal age / SAC at first by gestational age

    Day 0

  • Time from first retinal examination to diagnostic of severe ROP

    Day 0

Interventions

LaserPROCEDURE

Retinal laser photocoagulation

Anti VEGFPROCEDURE

Anti-VEGF intravitreous injection

Eligibility Criteria

Age0 Years - 31 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Cohort will be selected among all premature born between January 2016 and November 2020 and hospitalized in Centre Hospitalier Sud Francilien (Corbeil Essonnes 91) and Hopital Robert Debré (Paris 75).

You may qualify if:

  • Infant with gestational age \< 31 weeks and/or birth weight \< 1250 g
  • With at least one retinal examination
  • holders of the parental rights informed and not objecting to the study

You may not qualify if:

  • infants died before 28 days PNA
  • infants with hydrocephaly.
  • infants with significant congenital malformations or genetic abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LEROUX Pauline

Corbeil-Essonnes, France, 91106, France

Location

MeSH Terms

Conditions

Retinopathy of PrematurityBirth WeightPremature Birth

Interventions

Lasers

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Pauline LEROUX, MD

    Centre Hospitalier Sud Francilien

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2021

First Posted

December 10, 2021

Study Start

March 21, 2022

Primary Completion

June 16, 2022

Study Completion

June 16, 2022

Last Updated

November 26, 2024

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations